NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough-to-treat nerve cancer: three-way drug trial launches
Disease control Not yet recruitingThis study tests three different combinations of a radioactive drug (131I-MIBG) with other medicines (vorinostat and/or dinutuximab) in children and young adults (ages 1 to 29) whose neuroblastoma has come back or not responded to treatment. The goal is to see which combination s…
Matched conditions: NEUROBLASTOMA
Phase: PHASE2 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New cell therapy aims to supercharge Kids' immune cells after transplant
Disease control Not yet recruitingThis early-phase trial tests a new cell therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy is designed to boost the body's natural killer (NK) cells to better fight cancer. The main goals are to check if t…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
New hope for kids with relapsed cancers: targeted drug trial launches
Disease control Not yet recruitingThis study tests a new drug called ifinatamab deruxtecan (I-DXd) in children whose solid tumors have come back or did not respond to standard treatment. The drug works like a smart bomb, attaching to a protein on cancer cells and delivering a toxic payload to destroy them. The tr…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New CAR t cell therapy targets tough childhood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests whether a new cell therapy called B7-H3 CAR T cells is safe and can help children and young adults whose solid tumors have returned or stopped responding to standard treatments. About 40 participants will receive their own immune cells that have been …
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New scan could improve detection of Children's cancer
Diagnosis Not yet recruitingThis study tests a new imaging method called 18F-MFBG PET/CT to see if it works as well as or better than the current standard scan (123I-MIBG) for children with neuroblastoma, a type of nerve cancer. About 30 children with relapsed or hard-to-treat neuroblastoma will receive bot…
Matched conditions: NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 15, 2026 18:57 UTC
-
Spinal cord risk in Kids' tumor surgery: is Pre-Scan worth it?
Knowledge-focused Not yet recruitingThis study looks at whether doing a special X-ray (arteriography) before surgery to find a key spinal cord artery can prevent nerve damage in children with certain chest tumors. Researchers will review records of 150 children treated in France between 2005 and 2024. The goal is t…
Matched conditions: NEUROBLASTOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC